T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,010.00
-20.00 (-0.66%)
At close: Feb 20, 2026
Market Cap143.18B +59.5%
Revenue (ttm)20.67B +297.7%
Net Income-9.61B
EPS-371.66
Shares Out47.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume471,505
Average Volume685,701
Open3,060.00
Previous Close3,030.00
Day's Range2,945.00 - 3,110.00
52-Week Range1,127.00 - 4,925.00
Beta0.30
RSI40.36
Earnings DateMar 17, 2026

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

Financial Statements